03 Profile
Who Dr. Ewan Hunter is
Dr Ewan Hunter is Chief Data Officer at Oxford BioDynamics (OBD), an AIM-listed biotechnology company headquartered in Oxford. OBD develops precision diagnostic tests based on its EpiSwitch 3D genomics platform.
According to OBD's leadership page, he joined the company in 2012. He has led its biomarker direction, statistical data pipelines and machine learning, and now leads a team of biological data scientists. He has worked in biotech for more than 20 years, including at Silicon Genetics, Agilent Technologies, Thomson Reuters and Selventa.
He studied biochemistry at the University of Edinburgh and gained a PhD in statistical molecular neurobiology at King's College London. In September 2026 he was quoted on a University of East Anglia–led study that used OBD's EpiSwitch Orion platform to look at possible genomic links between long Covid, PTSD, rheumatoid arthritis, multiple sclerosis and ME/CFS.
Notable achievements
- 01
Co-author of a University of East Anglia–led study with Oxford BioDynamics, LSHTM and Cornwall Partnership NHS Foundation Trust on a possible shared genomic basis for chronic fatigue across long Covid, PTSD, rheumatoid arthritis, MS and ME/CFS (reported September 2026) Source ↗
- 02
Has led OBD's data science work since joining in 2012, including a team using BioBERT to build a knowledge base combining biological knowledge with proprietary EpiSwitch data Source ↗
- 03
Presented 'Unfolding the Genome's Natural Intelligence with EpiSwitch Orion' at PMWC 2026, where OBD formally launched EpiSwitch Orion Source ↗



